Imperial College London

Professor Mark Layton

Faculty of MedicineDepartment of Immunology and Inflammation

Professor of Practice (Haematology)
 
 
 
//

Contact

 

+44 (0)20 3313 2173m.layton

 
 
//

Assistant

 

Mrs Lisa Pape +44 (0)20 3313 1320

 
//

Location

 

4N3ACommonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Grace:2019:10.1182/blood-2019-123406,
author = {Grace, RF and Layton, DM and Galacteros, F and Barcellini, W and van, Beers EJ and Yaish, HM and Ravindranath, Y and Kuo, KHM and Sheth, S and Kwiatkowski, JL and Hua, L and Hawkins, PF and Mix, C and Glader, B},
doi = {10.1182/blood-2019-123406},
publisher = {AMER SOC HEMATOLOGY},
title = {Long-Term Safety and Efficacy of Mitapivat (AG-348), a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency: The DRIVE PK Study},
url = {http://dx.doi.org/10.1182/blood-2019-123406},
year = {2019}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Grace,RF
AU - Layton,DM
AU - Galacteros,F
AU - Barcellini,W
AU - van,Beers EJ
AU - Yaish,HM
AU - Ravindranath,Y
AU - Kuo,KHM
AU - Sheth,S
AU - Kwiatkowski,JL
AU - Hua,L
AU - Hawkins,PF
AU - Mix,C
AU - Glader,B
DO - 10.1182/blood-2019-123406
PB - AMER SOC HEMATOLOGY
PY - 2019///
SN - 0006-4971
TI - Long-Term Safety and Efficacy of Mitapivat (AG-348), a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency: The DRIVE PK Study
UR - http://dx.doi.org/10.1182/blood-2019-123406
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000577164600092&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER -